Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays

Targeted drugs have been widely used in the treatment of patients with lung cancer, particularly for those with non-small cell lung cancer (NSCLC). Plasma cell-free DNA is an emerging clinical tool for the detection of epidermal growth factor receptor (EGFR) gene mutation in patients with lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xi-Wen, Liu, Wei, Zhu, Xiao-Ya, Xu, Xiao-Xie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580028/
https://www.ncbi.nlm.nih.gov/pubmed/31115577
http://dx.doi.org/10.3892/mmr.2019.10259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580028/
https://www.ncbi.nlm.nih.gov/pubmed/31115577
http://dx.doi.org/10.3892/mmr.2019.10259

Ejemplares similares